These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16673466)

  • 1. Conclusions and recommendations from the Immunization Strategic Advisory Group.
    Wkly Epidemiol Rec; 2006 Jan; 81(1):2-11. PubMed ID: 16673466
    [No Abstract]   [Full Text] [Related]  

  • 2. Meeting of the immunization Strategic Advisory Group of Experts, November 2006--conclusions and recommendations.
    Wkly Epidemiol Rec; 2007 Jan; 82(1-2):1-16. PubMed ID: 17219693
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting of the immunization Strategic Advisory Group of Experts, November 2008--conclusions and recommendations.
    Wkly Epidemiol Rec; 2009 Jan; 84(1-2):1-16. PubMed ID: 19149014
    [No Abstract]   [Full Text] [Related]  

  • 4. [New ideas on the therapeutic effect of a combination of vaccines against pneumococcal, Haemophilus influenzae type b infection, and influenza in patients with chronic obstructive pulmonary disease].
    Kostinov MP; Zhestkov AV; Protasov AD; Magarshak OO; Kostinova TA
    Ter Arkh; 2015; 87(3):17-22. PubMed ID: 26027235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations.
    Wkly Epidemiol Rec; 2009 Jun; 84(23):220-36. PubMed ID: 19499606
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemophilus influenzae type b (Hib) Vaccination Position Paper – July 2013.
    Wkly Epidemiol Rec; 2013 Sep; 88(39):413-26. PubMed ID: 24143842
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines: more reasons to immunize.
    Consum Rep; 2006 Oct; 71(10):62. PubMed ID: 16981311
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of complex vaccination against pneumococcal, Haemophilus type b infections and influenza in patients with chronic obstructive pulmonary disease].
    Protasov AD; Zhestkov AV; Lavrenteva NE; Kostinov MP; Ryzhkov AA
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):80-4. PubMed ID: 21913397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines: worth paying for the value returned.
    Grabenstein JD
    Ann Pharmacother; 2002 Sep; 36(9):1471-2. PubMed ID: 12229878
    [No Abstract]   [Full Text] [Related]  

  • 11. Status of new vaccine introduction – worldwide, September 2016.
    Wkly Epidemiol Rec; 2017 Jan; 92(1):1-8. PubMed ID: 28058825
    [No Abstract]   [Full Text] [Related]  

  • 12. Meeting of the immunization Strategic Advisory Group of Experts, Geneva, 10-11 April 2006: conclusions and recommendations.
    Wkly Epidemiol Rec; 2006 May; 81(21):210-20. PubMed ID: 16729389
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on childhood and adolescent immunizations: selected review of US recommendations and literature: part 1.
    Fay KE; Lai J; Bocchini JA
    Curr Opin Pediatr; 2011 Aug; 23(4):460-9. PubMed ID: 21750429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age- and cause-specific childhood mortality in Lombok, Indonesia, as a factor for determining the appropriateness of introducing Haemophilus influenzae type b and pneumococcal vaccines.
    Nelson CM; Sutanto A; Gessner BD; Suradana IG; Steinhoff MC; Arjoso S
    J Health Popul Nutr; 2000 Dec; 18(3):131-8. PubMed ID: 11262765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.
    Alfonsi V; D'Ancona F; Giambi C; Nacca G; Rota MC;
    Health Policy; 2011 Dec; 103(2-3):176-83. PubMed ID: 22030308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.
    Levine OS; Knoll MD; Jones A; Walker DG; Risko N; Gilani Z
    Curr Opin Infect Dis; 2010 Jun; 23(3):236-41. PubMed ID: 20407316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines.
    Ishiwada N; Hishiki H; Nagasawa K; Naito S; Sato Y; Chang B; Sasaki Y; Kimura K; Ohnishi M; Shibayama K
    Vaccine; 2014 Sep; 32(42):5425-31. PubMed ID: 25131741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.
    Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India
    Indian Pediatr; 2009 Nov; 46(11):945-54. PubMed ID: 19955578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation at the crossroads: 9th National Immunisation/1st Asia-Pacific Vaccine Preventable Diseases Conference.
    McIntyre PB; Kelly HA; Mulholland EK
    Med J Aust; 2005 Jan; 182(1):15-6. PubMed ID: 15651941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.